Photodynamic Therapy (PDT) for Lower Urinary Tract Symptoms (PLUS)

Stopped early · Phase 2

Conditions studied: Prostatic Hyperplasia

In brief

The purpose of this study is to determine if transurethral photodynamic therapy with lemuteporfin has a therapeutic effect on lower urinary tract symptoms due to an enlarged prostate. Photodynamic therapy (known as "PDT") is a treatment that uses light to make a drug work. This means the drug is "light-activated". Light-activated drugs do not work until a certain color of light shines on the drug. When the drug and the light combine, they react together to destroy tissue. This study is investigating PDT with lemuteporfin as a possible treatment for an enlarged prostate. PDT with lemuteporfin may destroy overgrown prostate tissue and help urinary symptoms go back to normal.

Key facts

Study ID
NCT00116571
Run by
QLT Inc.
People needed
180
Starts
2005-05-01
Expected to finish
2006-12-01
Last updated by the study team
2006-10-03

Who can join

Age: 21 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.